A human abuse potential study of oral Rexista
Phase of Trial: Phase II
Latest Information Update: 10 Oct 2018
At a glance
- Drugs Oxycodone (Primary)
- Indications Pain
- Focus Registrational; Therapeutic Use
- Sponsors Intellipharmaceutics International
- 10 Oct 2018 According to an Intellipharmaceutics International clinical component of study has been completed. Bioanalytical samples and statistical analysis for such studies are pending. An update on the results will be provided once the analysis is complete.
- 16 Jul 2018 Status changed from planning to recruiting, as reported in the Intellipharmaceutics media release.
- 16 Jul 2018 According to a an Intellipharmaceutics media release, this trial is underway.